K. Connolly

Phase I trial of AEG35156 administered as a 7-day and 3-day continuous intravenous infusion in patients with advanced refractory cancer.

Stephen J. Morris, L. Aarons, M. Ranson, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Immediate surgery compared with short-course neoadjuvant gemcitabine plus capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable pancreatic cancer (ESPAC5): a four-arm, multicentre, randomised, phase 2 trial.

J. Neoptolemos, J. Graham, P. Ghaneh, 2022, The lancet. Gastroenterology & hepatology.

Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.

H. Gabra, A. Wyllie, J. Smyth, 1999, Cancer research.

The role of genomic Copy Number Variation (CNV) in osteoporosis

K. Connolly, 2012 .

Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): an international, randomised, open-label, multicentre, phase 2/3 trial

R. L. Hollis, H. Gabra, A. Secord, 2022, The Lancet.

Stable XIAP knockdown clones of HCT116 colon cancer cells are more sensitive to TRAIL, taxanes and irradiation in vitro

S. Guichard, D. Jodrell, R. Mitter, 2009, Cancer Chemotherapy and Pharmacology.

X-linked inhibitor of apoptosis (XIAP) in colorectal cancer models

K. Connolly, 2008 .

A Randomized Phase II/III Study to Assess the Efficacy of Trametinib in Patients with Recurrent or Progressive Low-Grade Serous Ovarian or Peritoneal Cancer

H. Gabra, A. Secord, R. Coleman, 2019, Gynecologic Oncology.

Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAF (V600E)-mutant metastatic colorectal carcinoma.

R. Epstein, D. Brungs, E. Szeto, 2013, Current oncology.

Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.

R. Epstein, P. Manders, P. Earls, 2014, Cancer treatment reviews.

A phase I trial of AEG35156 (XIAP antisense) administered as a continuous intravenous infusion in patients with advanced tumors.

M. Ranson, T. Ward, C. Dive, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.